Global Over-the-counter Pharmaceuticals Market 2012-2016

Global Over-the-counter Pharmaceuticals Market 2012-2016

Category : Healthcare

TOLL FREE
+1-971-202-1575
------------ Or -------------
help@researchbeam.com

TechNavio's analysts forecast the Global Over-the-counter (OTC) Pharmaceutical market to grow at a CAGR of 1.9 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing switch from prescription to OTC drugs. The Global Over-the-counter Pharmaceutical market has also been witnessing the trend of an increasing number of mergers and acquisitions. However, the increasing risks of side-effects could pose a challenge to the growth of this market. 

TechNavio's report, the Global Over-the-counter Pharmaceutical Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Over-the-counter Pharmaceutical market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

The key vendors dominating this market space are Bayer Healthcare AG, Johnson & Johnson, GlaxoSmithKline plc, and Novartis International AG.

The other vendors mentioned in the report are Sanofi S.A., Reckitt Benckiser plc, Boehringer Ingelheim GmbH , Merck and Co. Inc., Pfizer Inc., Takeda Pharmaceutical Co. Ltd., Roche Holding Ltd., Procter and Gamble, Taisho Pharmaceutical, Bristol Myers Squibb Co., Schering-Plough Corp., Eisai Co. Ltd., Mitsubishi Tanabe Pharma Corp., Sigma Pharmaceuticals plc, Hubei Biocause Heilen Pharmaceutical Co. Ltd., United Laboratories Inc., Daewoong Pharmaceutical Co. Ltd., Bukwang Pharmaceutical Co. Ltd., Vida Laboratories Ltd., and Cipla Ltd.

Key questions answered in this report:
What will the market size be in 2016 and what will the growth rate be? 
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

01. Executive Summary

02. Introduction

03. Market Coverage


Business Overview

Product Offerings

04. Market Landscape

Market Size and Forecast

Market Segmentation

04.1 Five Forces Analysis

05. Geographical Segmentation

06. Key Leading Countries


The US

Japan

China

07. Vendor Landscape

Product Portfolio Matrix

08. Buying Criteria

09. Market Growth Drivers

10. Drivers and their Impact

11. Market Challenges

12. Impact of Drivers and Challenges

13. Market Trends

14. Key Vendor Analysis


14.1 Bayer HealthCare AG

Business Overview

Key Information

SWOT Analysis

14.2 Johnson & Johnson

Business Overview

Key Information

SWOT Analysis

14.3 GlaxoSmithKline plc

Business Overview

Key Information

SWOT Analysis

14.4 Novartis International AG

Business Overview

Key Information

SWOT Analysis

15. Other Reports in this Series



List of Exhibits:

Exhibit 1: Global Over-the-counter Pharmaceuticals Market 2012–2016 (US$ billion)

Exhibit 2: Global Over-the-counter Pharmaceuticals Market by Product Segmentation

Exhibit 3: Global Over-the-counter Pharmaceuticals Market by Product Segmentation 2012

Exhibit 4: Global Over-the-counter Pharmaceuticals Market by Geographical Segmentation 2012

Exhibit 5: Global Over-the-counter Pharmaceuticals Market by Vendor Segmentation 2012

Exhibit 6: Business Segmentation of Bayer HealthCare AG

Exhibit 7: Business Segmentation of Johnson & Johnson

Exhibit 8: Business Segmentation of GlaxoSmithKline plc

Exhibit 9: Business Segmentation of Novartis International AG


Enquiry Before Buy
image
Can´t read the image ? refresh here.